Crystal structure of an acetylcholinesterase–fasciculin complex: interaction of a three-fingered toxin from snake venom with its target  by Harel, Michal et al.
Crystal structure of an acetylcholinesterase-fasciculin
complex: interaction of a three-fingered toxin from
snake venom with its target
Michal Harel 1 , Gerard J Kleywegt2, Raimond BG Ravelli3 ,4,
Israel Silman4 ,5 and Joel L Sussman 1, 4*
1 Department of Structural Biology, Weizmann Institute of Science, Rehovot 76100, Israel, 2Department of Molecular Biology, Biomedical
Centre, Uppsala University, Box 590, S-751 24 Uppsala, Sweden, 3Department of Crystal and Structural Chemistry, Bijvoet Center for
Biomolecular Research, Padualaan 8, 3584 CH Utrecht, The Netherlands, 4Department of Biology, Brookhaven National Laboratory,
Upton, NY 11973, USA and 5Department of Neurobiology, Weizmann Institute of Science, Rehovot 76100, Israel
Background: Fasciculin (FAS), a 61-residue polypeptide
purified from mamba venom, is a three-fingered toxin
which is a powerful reversible inhibitor of acetylcholin-
esterase (AChE). Solution of the three-dimensional structure
of the AChE/FAS complex would provide the first struc-
ture of a three-fingered toxin complexed with its target.
Results: The structure of a complex between Torpedo
californica AChE and fasciculin-II (FAS-II), from the venom
of the green mamba (Dendroaspis angusticeps) was solved by
molecular replacement techniques, and refined at 3.0 A
resolution to an R-factor of 0.231. The structure reveals a
stoichiometric complex with one FAS molecule bound to
each AChE subunit. The AChE and FAS conformations in
the complex are very similar to those in their isolated
structures. FAS is bound at the 'peripheral' anionic site of
AChE, sealing the narrow gorge leading to the active site,
with the dipole moments of the two molecules roughly
aligned. The high affinity of FAS for AChE is due to a
remarkable surface complementarity, involving a large con-
tact area (-2000 A2) and many residues either unique to
FAS or rare in other three-fingered toxins. The first loop,
or finger, of FAS reaches down the outer surface of the
thin aspect of the gorge. The second loop inserts into the
gorge, with an unusual stacking interaction between Met33
in FAS and Trp279 in AChE. The third loop points away
from the gorge, but the C-terminal residue makes contact
with the enzyme.
Conclusions: Two conserved aromatic residues in the
AChE peripheral anionic site make important contacts with
FAS. The absence of these residues from chicken and insect
AChEs and from butyrylcholinesterase explains the very
large reduction in the affinity of these enzymes for FAS.
Several basic residues in FAS make important contacts with
AChE. The complementarity between FAS and AChE is
unusual, inasmuch as it involves a number of charged
residues, but lacks any intermolecular salt linkages.
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Introduction
The venoms of elapid snakes, including the Asian cobras
and kraits, and the African mambas, contain a number of
small proteins, 60-70 amino acid residues long, which
display a broad spectrum of toxic activities [1]. Among
the best studied are the o-neurotoxins of the venoms of
kraits and cobras, such as ao-bungarotoxin from the For-
mosan krait, Bungarus multicinctus [2], and the somewhat
shorter ot-cobratoxins isolated from the venoms of vari-
ous cobras such as the Siamese cobra, Naja naja siamensis
[3], both of which serve as potent and specific blockers of
the nicotinic acetylcholine receptor [4]. Other toxins of
this family serve as blockers of K+ channels and
Ca2+ channels [5], as muscarinic receptor agonists [6] and
as anticholinesterase agents [7]. Despite their diverse bio-
logical activities, these toxins display substantial sequence
and structural homology. X-ray and NMR studies show
that the toxins share a common structural motif: a core,
containing four disulfide bridges, from which three loops
protrude, roughly like the central fingers of a hand [8].
Accordingly, the family is known as the three-fingered
toxin family [9]. Superposition of the structures of
different toxins reveals that, whereas the structure of the
central core is conserved, the orientation of the fingers
can vary considerably [5], suggesting that they serve as
determinants of biological specificity. Until now, how-
ever, no three-dimensional structure has been available of
a complex of a three-fingered toxin with its target.
Acetylcholinesterase (EC 3.1.1.7; AChE) is a synaptic
enzyme the principal role of which is believed to be the
termination of impulse transmission at cholinergic
synapses by rapid hydrolysis of the neurotransmitter,
acetylcholine (ACh) [10]. In accordance with its biologi-
cal function, AChE possesses unusually high catalytic
activity, especially for a serine hydrolase, functioning at a
rate which approaches limitation by diffusion control
[11]. Unexpectedly, the three-dimensional (3D) structure
of AChE revealed that its active site is located near the
bottom of a deep and narrow gorge, the surface of which
is largely composed of the rings of an array of conserved
aromatic amino acids [12]. Moreover, the so-called
'anionic' subsite, which is recognized by the quaternary
group of the positively charged substrate, ACh, is not
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composed of a cluster of carboxylic groups, as was previ-
ously thought to be the case [13], but consists primarily
of the rings of two of the conserved aromatic amino
acids, Trp84 and Phe330. These residues are probably
involved in electrostatic interactions with ACh through
the r-electrons of their rings [14-16].
The existence of a second anionic site, known as the
'peripheral' site, was recognized many years ago, on the
basis of the high affinity of the enzyme for bisquaternary
ligands [17]. Various bulky ligands, such as the alkaloid
d-tubocurarine, and the fluorescent probe propidium,
inhibit AChE non-competitively by binding at this site
[18]. Several lines of evidence suggest that the peripheral
site is located at the top of the active-site gorge. Firstly,
the layout of the active-site gorge [12]. Secondly, the
crystal structure of a complex of Torpedo AChE with the
bisquaternary inhibitor decamethonium [14]. And lastly,
modeling studies of human butyrylcholinesterase
(BuChE) [19], which is not susceptible to peripheral site
inhibitors. Like the anionic subsite of the active site,
conserved aromatic residues were postulated to play an
important role in this site, in particular Tyr70, Tyrl21
and Trp279 [12].
Electrostatic calculations reveal that the AChE molecule
possesses a large dipole moment oriented in such a way
that it would serve to attract the ACh down the gorge
towards the active site [20]. The contribution of this field
to the rapid turnover of AChE is the subject of substantial
controversy [21-23].
Many of the toxins in the venoms of the elapid snakes are
directed towards components of the cholinergic synapse,
both presynaptic and postsynaptic [1,9]. It is, therefore,
perhaps not surprising that one such toxin, fasciculin
(FAS), is directed towards the synaptic enzyme AChE [7],
resulting in severe, generalized and long-lasting fascicula-
tions of skeletal muscle due to accumulation of increased
levels of ACh within the synaptic cleft [24]. The three
fasciculins described to date are 61-amino acid peptides,
isolated from mamba venoms. They are potent reversible
inhibitors of mammalian and electric organ AChEs, with
inhibitory constant values of-10-1 1 -10- 12 M [25]. Fasci-
culins-I (FAS-I) and II (FAS-II), isolated and purified
from the venom of the green mamba (Dendroaspis angusti-
ceps), have been crystallized, and their structures deter-
mined to 1.9 A [8] (PDB entry 1FAS) and 2.0 A [26]
(PDB entry 1FSC), respectively. These crystallographic
studies revealed that, as predicted from the sequence
similarities, they display strong structural homology with
other three-fingered toxins [5,6,8,9].
The fact that the 3D structure of AChE [12] became
available at about the same time as that of FAS-I [8] stim-
ulated a wave of experimental studies aimed at elucidat-
ing the molecular basis for inhibition, using conventional
enzyme kinetics [27-29], as well as chemical modifica-
tion [25,30,31] and site-directed mutagenesis [29,32]. A
theoretical study, in which docking of FAS onto the
AChE structure was attempted, has also been published
[33]. Chemical modification suggested participation of a
number of conserved basic residues of FAS in the inter-
action with AChE [25,30], and further suggested that the
interaction took place at the peripheral anionic site of
AChE, which is located at the mouth of the active-site
gorge [31]. Site-directed mutagenesis has provided evi-
dence for participation of aromatic residues from the
peripheral site of mouse AChE (Tyr70, Tyrl21 and
Trp279) in the interaction with FAS [32]. A plausible
mechanism for the mode of action of FAS would be
blockage of the entrance to the active-site gorge, thus
preventing access of the substrate to the active site.
Recent studies suggest, however, that both substrates and
inhibitors have access to the active site in the AChE/FAS
complex [27-29]. Solution of the 3D structure of the
AChE/FAS complex provides direct insight into the
mode of action of FAS, as well as delineating the struc-
tural features, in both enzyme and toxin, which govern
the specificity and potency of the interaction. Here we
describe and analyze the 3D structure of a complex of
Torpedo AChE with FAS-II.
Results and discussion
Description of the structure
The structure of the Torpedo AChE/FAS-II complex was
solved and refined at 3.0 A by standard crystallographic
techniques. Details are given in the Materials and methods
section and in Tables 1 and 2. Figure la shows an
overview of the complex of the two proteins and Fig-
ure lb shows the physiological dimer of the AChE/FAS-II
complex. It is clear from Figure lb that the two FAS mol-
ecules sit on opposite ends of the AChE dimer and do not
interact with one another. Figure 2 shows a representative
section of the final electron-density map.
The structures of both AChE and FAS-II in the complex
are very similar to their structures in the uncomplexed
forms. The root mean square deviation (rmsd) for 528
Ca atoms in AChE, compared with the starting model
for refinement [14], is 0.49 A. Shifts greater than 1 A
occur for residues at the termini as well as for residues
281, 283, 333-337, 349-351 and 485. (Residue number-
ing for AChE here, and throughout the paper, is based
on Torpedo calfornica AChE [34].) Apart from the termini,
most of the shifted residues are in areas which form part
of the AChE/FAS-II interface.
The rmsd for 61 FAS-II Cot atoms is 0.79 A, compared
with the X-ray structure of the toxin alone [26], with
shifts greater than 1 A observed for some residues in the
protein-protein interface (fingers I and II, residues 11,
12, 28-32), as well as for residues 19, 44 and 46.
As seen in Figure la, a large number of residues interact
upon complex formation. The total loss of accessible sur-
face area is -2000 A2, at the top end of the scale observed
for protein-protein hetero-complexes (excluding throm-
bin-inhibitor complexes) [35]. For comparison, in the
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complex between Fab HyHEL5 and lysozyme (PDB
entry 3HFL) -1700 A2 of surface area are buried; in the
barnase-barstar complex (PDB entry 1BGS), -1600 A2;
in the subtilisin-eglin complex (PDB entry 1CSE),
-1500 A2 and in the complex of trypsin with bovine pan-
creatic trypsin inhibitor (PDB entry 1BRB), -1400 A2.
All these calculations of buried surface utilized a 1.4 A
probe radius [35].
The AChE/FAS-II interface can be divided roughly into
three regions, which we denote A, B and C (see Table 3
and Figs 2,3).
Interface regions between AChE and FAS
Region A consists of residues 68-90 in AChE (i.e. the o
loop [36] which contains residues belonging to both the
anionic site and the peripheral site) and loops I and II of
FAS. Loop I of FAS is held in a vice-like grip by AChE.
It interacts with the outer face of the thin aspect [36] of
the active-site gorge (Asn85) which has the anionic
site on its inner face (near Trp84), and with residues at
the top of the gorge within the peripheral site (Tyr70
and Val71) (see Figs 2,3a). Contacts in this region
involve only hydrophobic interactions and main-chain
to side-chain hydrogen bonds.
Region B comprises residues 272-289 in AChE (corre-
sponding to part of the peripheral site [14]). These
residues interact nredominantlv (but not exclusivelv) with
the second finger of FAS via polar interactions, several
main-chain to side-chain hydrogen bonds, and additional
hydrophobic interactions. Interestingly, one residue in
FAS, Thr8, interacts both with Val71 (in region A) and
Asp276 (in region B) (see Figs 2, 3a and 3b). The car-
boxylate oxygen atoms of Asp285 are within hydrogen-
bonding distance of the backbone atoms of Pro30 in
FAS, suggesting that this aspartate is protonated.
The most striking hydrophobic interaction is the stacking
between the side chains of Met33 in FAS and Trp279 in
AChE (Fig. 3b): the Sb-Ce moiety of Met33 stacks paral-
lel to the indole ring of the tryptophan, with the sulfur
atom positioned roughly above the six-membered ring
and the methyl group above the five-membered ring.
Although such stacking interactions are rare, they are not
unknown. For instance, in AChE itself, Met83 stacks in a
similar way with Trp84 in the anionic site. A search of the
PDB using SPASM (GJK, unpublished program) revealed
other proteins in which a methionine and a tryptophan
residue interact in a similar way. Examples include glucose
oxidase (Trpl31-Met268; PDB entry 1GAL), guinea fowl
egg-white lysozyme (Trp28-Met105; PDB entry 1HHL),
renin (Trp299-Metl94; PDB entry RNE), and deoxy-
hemoglobin (Trpl30-Metl 14; PDB entry 2HBG).
Residues 279-284 in region B have relatively poor den-
sity in the 3.0 A 2Fo-Fc map. However, in the 3.2 A and
cross-crystal averaged map it is shown unambiguously
that both the main-chain trace and the side-chain orien-
tations for tins region are essentially correct.
Region B also contains a crystal packing artifact between
AChE and FAS, namely the formation of a zinc-binding
site (zinc being part of the crystallization liquor) in which
the zinc ion is coordinated by Asp285 in AChE, His29 in
FAS, and Glu49 from a symmetry-related copy of the
AChE molecule. It is possible that the histidine and
the aspartate would form an additional side-chain to
side-chain hydrogen bond under physiological conditions
(in the absence of zinc).
Region C comprises residues 334-358 in AChE (at the
top of the gorge, see Fig. la). This region has a few
Table 1. Data collection and processing statistics.
Data set 1 2
Cell axes a, b, c (A) 87.4, 115.0, 67.5 87.1, 116.8, 72.7
Diffraction limit (A) 3.0 3.2
No. of observations 48 744 41 880
No. of independent reflections 14 206 12 382
Highest resolution shell (A) 3.11-3.0 3.3-3.2
Completeness (%): all data 97.7 95.6
highest resolution shell 93.7 62.6
Rsym (on )* (%): all data 10.5 5.9
highest resolution shell 30.3 32.3
I/oa(l): all data 10.7 18.8
highest resolution shell 3.5 3.3
*Rsm(l)=]hklti I li(hkl)-<i(hkl)> /'hklili(hkl), where <I> is the average
intensity of the i observations of reflection hkl.
Table 2. Refinement and model statistics.
Resolution range (A) 8.0-3.0
Number of reflections (F>0) 12 579
R-factor* 0.231
Last-recorded value of Rfreet 0.315
No. of protein atoms (532+61 residues; Z>1) 4690
No. of hetero atoms
(carbohydrate, water, 2 Zn2+ ions) 52
Temperature factors (grouped one B per residue)
Average B-factor for all protein atoms (A2) 19.5
Geometry: rms deviations from ideal values [53,61]
Bond lengths (A) 0.008
Bond angles () 1.4
Dihedral angles (0) 24.0
Improper torsion angles (°) 1.2
Ramachandran plot (non-Gly, non-Pro residues) [641
Residues in most favored regions (%) 81.9
Residues in additional allowed regions (%) 16.7
Residues in generously allowed regions (%) 1.0
Residues in disallowed regions (%) 0.4
Structural quality
Residues with unusual peptide orientations (%) [54] 2.7
Residues with non-rotamer
side-chain conformations (%) [54] 11.5
Residues with poor density
(real-space R-factor>0.40) (%) [54] 2.4
Overall G-factor [641 +0.23
Overall DACA score [65] -1.00
*R-factor=,hkl I Fobs(hkl) - Fcalc(hkl) I/-,hkl, I Fobs(hkl) ,
where Fbs(hkl) and Fcalc(hkl) are the observed and calculated
values, respectively, for structure factor hkl. tRfree is
equivalent to R-factor for a randomly selected 7% subset of
reflections not used in structure refinement.
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Fig. 1. AChE/FAS-II complex. (a) Stereo
ribbon drawing of AChE (grey) and
FAS-II (black) showing the interactions
between them. Residues which partici-
pate in hydrophobic interactions are
green, those involved in hydrogen
bonds are yellow, and those participat-
ing in both kinds of interaction are red.
L1, L2 and L3 denote loops 1, II and III,
respectively. (b) Physiological dimer of
AChE/FAS-II complexes. The AChE mol-
ecules are color-ramped from blue at
their N termini to red at their C termini.
The FAS molecules are shown in
magenta.
Fig. 2. Representative portion of the
final 3F0-2Fc map of the AChE/FAS-II
complex for part of interface region A. It
shows the interaction between Asn85
(AChE) and Argl 1 (FAS-II). The segment
Glu82-Asn85 of AChE is displayed. In
addition, the unusual carboxylate inter-
action between Glu73 and Glu82 in
AChE is shown.
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Table 3. Surface accessibilities and interactions of residues at the AChE/FAS-II interface.
Residue B-factor Surface
(A2 ) loss (A2)*
Hydrogen
bonds (A)
Hydrophobic
interactions (A)
Residue B-factor Surface
(A2) loss (A2 )*
3.7 64 (4)
24.5 53 (4)
OH-Val34 O (3.2)
N-Thr8 O0 (2.9)
Glu73 22.1 84 (0) O-Arg37 NYl (2.8)
O-Arg37 Nsq2 (2.7)
Gln74 14.0 62 (15)
Phe75 12.4 18 (17)
Pro76 12.4 93 (10)
33 (18)
10 (8)
9 (12)
10 (70)
26 (46)
23.9 21 (76)
10.4 21 (1)
53.8 51 (67)
53.8 67 (9)
O-Argl 1 N2 (2.9)
O-Argl 1 N2 (3.6)
C81-Thr8 Cy2 (3.7)
Cel-Thr8 Cy2 (3.9)
Cyl -Argl 1 Cy (4.0)
Cy2-Thr9 Ca (3.7)
Cy2-Thr9 C (3.6)
C13-His6 C82 (3.7)
C13-His6 CE1 (3.6)
Cy-His6 C82 (3.9)
Cy-Ala12 C13 (3.8)
C8-Argl 1 Co (3.8)
CS-Alal 2 C13 (3.8)
C8-Alal2 C13 (3.2)
Cco-Tyr61l CC (3.9)
C-Arg37 CC (4.0)
CS-Tyr61 C2 (4.0)
C6-Tyr61 Ce2 (3.9)
CP3-Tyr4 C61 (4.0)
C3-Tyr4 Cel (3.9)
CP3-Alal 2 C!3 (3.9)
Cy-Arg37 CC (3.3)
C3-Argl I CC (4.0)
Cc-Thr9 C (3.6)
C13-Thr8 Cy2 (4.0)
Cy2-Thr8 C3 (3.9)
Cy2-Thr9 Cy2 (4.0)
C81-Thr9 Cy2 (3.3)
081-Thr8 Oyl (2.6)
082-Thr8 Oyl (3.6)
O-Arg27 N1 (2.8) C13-Met33 S (3.6)
Cy-Met33 S8 (3.1)
C82-Met33 S8 (3.2)
C82-Met33 C (3.7)
CE2-Met33 58 (3.7)
CE2-Met33 CE (3.7)
Ce3-Met33 S (3.7)
C61-Met33 SS (3.6)
CC2-Met33 C (3.9)
Region B
(continued)
Asn280
Leu282
Asp285
Ser286
Arg289
Region C
Tyr334
Gly335
Lys341
Asp342
Leu358
FAS-II
Tyr4
His6
Th r7
Thr8
Thr9
Ser 10
Arg 1
Ala12
Arg24
Arg27
His29
Pro30
Pro31
Lys32
Met33
Vai34
Leu35
Arg37
Asn47
Tyr61
14.6 27 (55)
41.7 42 (14)
39.7 60 (54)
19.0 40 (4)
2.0 5 (36)
10.5 67 (19)
42.7 47 (16)
19.1 12 (31)
32.8 11 (109)
32.8 14 (22)
10.0
2.0
6.5
2.0
10.0
20.1
22.6
12.3
2.0
2.0
14.6
6.6
2.0
22.7
17.8
7.2
5.9
15.1
49.8
25.0
081-Pro30 N (3.2)
081-Pro30 O (3.0)
N-Pro30 O (3.1)
O-Lys32 N (2.6)
NC-Tyr61 O09 (3.0)
C1-Arg27 CC (3.7)
C81-Pro31 C8 (3.8)
C81-Pro31 Cy (3.8)
Cy-His29 C3 (3.6)
Ca-Lys32 Cy (3.8)
C(a-Lys32 C (3.8)
C-Pro30 Cy (3.9)
16 (24)
15 (12)
9 (69)
97 (1)
107 (27)
16 (38)
124 (104)
31 (23)
13 (38)
73 (26)
22 (85)
85 (11)
68 (15)
49 (85)
83 (5)
40 (0)
31 (23)
29 (4)
22 (77)
100 (85)
Residues in AChE that lose more than 5 A2 of accessible surface area upon complex formation with FAS-II are listed together with their interactions
with residues in FAS-II. For possible hydrogen bonds, a distance cutoff of 3.6 A was used; for hydrophobic interactions, a distance cutoff of 4.0 A was
used. These rather high cutoff values were chosen to take into account the uncertainty in the atomic positions. *Loss of accessible surface area upon
complex formation. The amount of exposed surface remaining in the complex shown in parentheses.
interactions with residues in loop II of FAS and with
Tyr61l at the C terminus. Thus, FAS uses not only loops I
and II, but also the C-terminal tyrosine (which is con-
served in the fasciculins, but rare in other toxins) to
interact with the top of the gorge of AChE.
In summary, the interface between AChE and FAS-II
consists largely of hydrophobic interactions, together
with three main-chain to main-chain hydrogen bonds,
eight main-chain to side-chain hydrogen bonds, and only
three polar side-chain interactions. The striking absence
of salt links in the interface cannot be attributed to a lack
of charged residues. Five acidic residues from AChE
(Glu73, Glu82, Asp276, Asp285 and Asp342) and five
basic residues from FAS-II (Argl 1, Arg24, Arg27, Arg37
and Lys32) are found at the interface. Perhaps the pH of
the crystallization solution (-5.2) also plays a role in
determining the nature of interface contacts, inasmuch as
some of the acidic residues may well be protonated, thus
favoring hydrogen-bonding interactions. In AChE, both
Glu73 and Glu82 are probably protonated, as they form
double hydrogen bonds through their carboxylate groups
(Fig. 2). Asp276 and Asp285 are involved in hydrogen
bonds with residues in FAS-II, and Asp285, in addition,
coordinates the zinc ion mentioned earlier. Asp342
appears to have no hydrogen-bonding interactions in our
structure. Of the basic residues in FAS, the amino group
of Lys32 has no apparent hydrogen-bonding interactions.
Three of the four arginine residues (Argl 1, Arg27 and
Arg37) form hydrogen bonds with atoms in AChE. The
NE atom of Arg24 forms an internal hydrogen bond to
Oy of Ser26 in FAS; in addition, its guanidino Nrll
atom forms an internal salt link with the C-terminal car-
boxyl group of Tyr61. Arg27 appears to play a role in
orienting or stabilizing the Pro-cis-Pro turn in finger II:
its NE atom is within hydrogen-bonding distance of the
Region A
Tyr70
Va171
Hydrogen
bonds (A)
Hydrophobic
interactions (A)
23.6
9.6
15.9
2.0
2.0
Glu82
Asn85
Pro86
Asn87
Met90
Region B
Gln272
lle275
Asp276
Trp279
v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
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Fig. 3. Details of the AChE/FAS-II
interface with interacting residues
shown as ball-and-stick models. The let-
ters 'a' or 'f' after the residue number
refer to AChE and FAS-II, respectively.
(a) Region A covering AChE residues
68-90, showing the large number of
hydrophobic interactions. (b) Region B,
covering AChE residues 271-289.
carbonyl oxygen atoms of His29 and Pro31, whereas its
guanidino Nql1 atom forms a hydrogen bond with the
carbonyl oxygen of Pro30.
There exists a remarkable shape complementarity
between AChE and FAS-II in the interface. Figure 4
shows how the first two fingers of FAS fit snugly into
depressions in the surface of AChE near the mouth of
the gorge. This figure also suggests that FAS blocks the
entrance to the gorge. This is confirmed by volume cal-
culations as shown in Figure 5. Without bound FAS, the
gorge is connected to the external solvent (i.e. accessible
to a probe with a radius of 1.4 A), but in the complex
the entrance is sealed.
Fig. 4. Complementarity of the surfaces of AChE and FAS-II in
their complex. The coloring scheme for AChE and FAS-II is the
same as in Figure lb. The semi-transparent van der Waals
surface of AChE is shown in blue.
For the reasons outlined below, we are confident that the
interface described here is the one existing under physio-
logical conditions. However, due to crystal packing there
are additional interactions between AChE and FAS-II, as
well as between symmetry-related FAS molecules. The
symmetry contacts between AChE and FAS-II (in addi-
tion to those involving the zinc ion mentioned earlier)
involve a few hydrophobic and polar interactions
between a limited set of residues: Glu49, Pro50, Arg174,
Met175, Gln178 and Gly214 in AChE, and His29,
Gly44, Asp45, Asp46 and Asn47 in FAS-II.
Theoretical docking studies by van den Born et al. [33]
produced a set of three models for the AChE/FAS com-
plex. For each model, a set of possible electrostatic,
hydrophobic and polar interactions was listed. Of the
hydrophobic contacts listed, none are observed in our
crystal structure, and only one polar interaction actually
corresponds to an observed hydrogen bond (Glu73 in
AChE to Arg37 in FAS, which they proposed in their
model complex #58; the other six polar interactions
listed for this complex do not occur). Because many
models were generated, but only a few were chosen for
further scrutiny, selection of those models may well have
been driven by the anticipation of electrostatics-driven
complex formation.
Specificity of interaction
The structure we have determined clearly demonstrates
that, as predicted [32], FAS-II inhibits Torpedo AChE by
binding at the top of the active-site gorge, overlapping
the peripheral anionic site. However, the FAS orientation
does not conform to any of those predicted by docking
studies [33]. The FAS-II molecule makes contact
through its first two fingers, that is loops I and II, with
loop III actually pointing away from the AChE molecule.
A principal point to be emphasized is that there is little
difference in the overall conformations of either FAS-II
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Fig. 5. A slice through the active-site
gorge of AChE. The bottom of the gorge
is indicated by Trp84 (ball-and-stick)
and the peripheral site by Trp279. The
coloring scheme for AChE and FAS-II is
the same as that in Figure lb. (a) AChE
alone - the gorge is accessible to exter-
nal solvent. (b) The AChE/FAS-II com-
plex, with the gorge blocked by FAS-II.
or Torpedo AChE in the complex relative to their native
structures. The high affinity observed must, therefore,
result from a high degree of complementarity. This, in
turn, arises from a rather large contact area, as well as
involvement in the interface of a substantial number of
residues either unique to the fasciculins, or occurring
only rarely in other members of the three-fingered toxin
family (Fig. 6). The crystal structures of FAS-I and
FAS-II are very similar. They have an rmsd of 0.6 A for
53 out of 61 C atoms; this excludes the first finger
(residues 6-13), which is in a markedly different confor-
mation in the crystal structures of FAS-I and FAS-II (up
to 10 A difference). In the crystal structure of FAS-I, this
region has relatively high temperature factors [8], and was
shown to be flexible in a number of three-fingered toxins
in solution [5]. If FAS-I were placed, as a rigid body, in
the position and orientation of FAS-II in the complex,
loop I would clash with residues 72-77 of AChE.
Because the sequences of FAS-I and FAS-II are virtually
identical (the only change is Tyr47-Asn), and the two
toxins bind to AChE with similar affinity, it is likely that
FAS-I adopts a very similar conformation to that of
FAS-II when complexed with AChE.
AChEs of fish and mammals, but not BuChEs, are sus-
ceptible to inhibition by FAS. Several insect, bird and
reptile AChEs are, however, poorly inhibited by FAS.
The present model of the AChE/FAS complex, com-
bined with alignments of various esterase sequences,
provides hints as to the identity of the residues in AChE
that are responsible for this inhibition (Fig. 7). Clearly,
key residues which are responsible for affinity, or lack
thereof, must be buried in the complex, must not be
identical in BuChE and AChE, and are probably strictly
conserved in the susceptible AChEs. Figure 7 shows that
only residues 70, 71 and 279 strictly satisfy all these crite-
ria. In BuChEs, Val71 is replaced by isoleucine, which is
a conservative substitution, but Tyr70 is replaced by
asparagine and Trp279 by arginine, alanine or valine.
These non-conservative changes at positions 70 and 279
are bound to interfere with, or preclude, the favorable
hydrophobic interactions in which these two residues are
involved in the AChE/FAS complex.
Role of aromatic residues
Site-directed mutagenesis of mouse recombinant AChE
pointed to an important role for three conserved aro-
matic residues, namely Tyr70, Tyrl21 and Trp279, in the
interaction with FAS-II [32]. All three are located near
the top of the gorge, with their aromatic rings pointing
into it, and have been assigned to the peripheral site also
on the basis of their involvement in interactions with
other peripheral-site-specific inhibitors [19,37-40]. Our
3D structure shows that two of these residues, Tyr70 and
Trp279, interact with residues in FAS-II. The third
residue, Tyrl21, is not in direct contact with FAS-II; it is
located inside the gorge and is surrounded by six other
aromatic residues. A role for this residue in the binding
Fig. 6. Comparison of the amino acid sequences of fasciculins (FAS-I, FAS-II and FAS-III) with 163 other non-FAS toxin sequences that
are found in the SWISS-PROT database [68]. Residues that occur in the fasciculins but do not occur in that position in any of the other
toxins are indicated in red; those that are rarely found in other toxins (occurring in five or fewer of these sequences) are in bold. The
amino acids that make up the three fingers are underlined. Asterisks indicate those residues that lose more than 5 A2 of accessible sur-
face area in the complex with AChE. The fasciculins and other toxins were aligned using the PILEUP program [69] of the GCG package
(Genetics Computer Group, Madison, Wisconsin).
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Fig. 7. Comparison of the amino acid sequences of Torpedo AChE and human BuChE with all other sequenced AChEs and BuChEs in
the three regions of AChE that interact with FAS in the complex. The AChE and BuChE sequences were taken from the 'ESTHER' server
[70] (URL: http/www.montpellier.inra.fr:70/1/cholinesterase). White text indicates residues conserved in both AChEs and BuChEs;
residues conserved in AChEs only are indicated in green and those conserved in BuChEs only are in red; asterisks indicate AChE
residues interacting with FAS, and triangles mark residues that lose more than 20 A2 of accessible surface area upon binding FAS.
site for the toxin was assigned on the basis of the
Tyrl21--Gln mutation, which reduced affinity towards
FAS -100-fold [32]. However, mutation of the corre-
sponding residue to alanine, in human recombinant
AChE, slightly increased affinity for the peripheral-site
ligand, propidium [40]. The introduction of a polar glut-
amine residue into the aromatic cluster lining the wall of
the gorge probably has an indirect effect on the geometry
of the binding site for FAS.
Participation of Tyr70 and Trp279 in the binding site for
FAS-II of Torpedo AChE is also in agreement with the
fact that these two residues, as well as Tyrl21, are not
conserved in BuChE, which shows a low affinity for
FAS, as well as for the low molecular weight peripheral-
site ligands [7,24,32]. It was elegantly demonstrated [32]
that production of a triple mutant in mouse AChE, in
which the residues equivalent to Torpedo Tyr70, Tyrl21
and Trp279 were replaced by asparagine, glutamine and
arginine, respectively, reduced its affinity for FAS by
eight orders of magnitude, to a value very similar to that
observed for wild-type BuChE. The affinity for FAS for
the double mutant, in which only the two residues
equivalent to Tyr70 and Trp279 in Torpedo were mutated,
was only slightly greater. Furthermore, as already men-
tioned, the AChEs of insect, avian and reptile species all
display reduced affinity for FAS [7]. Drosophila AChE
lacks all three of the conserved aromatic residues at the
top of the gorge [41], and chicken AChE lacks both
Tyr70 and Trp279 [39], whereas AChE purified from the
venom of Bungarus fasciatus (X Cousin et al., personal
communication) lacks only Tyr70. It is interesting that in
B. fasciatus AChE, Asp285 is substituted by lysine. When
this lysine is replaced by aspartate, by site-directed muta-
genesis, the affinity for FAS and peripheral-site ligands is
substantially increased (X Cousin et al., personal commu-
nication). This is in agreement with the observed inter-
action of Pro30 with Asp285 and our prediction of an
interaction between His29 and Asp285 (see above) in the
AChE/FAS-II complex under physiological conditions.
Comparison of the sequences of the three known
fasciculins with those of 163 other toxins reveals that a
number of residues which are involved in the interface
with AChE are unique to the fasciculins or are rarely
found in other toxins (Fig. 6). Based on the alignment,
Met2, Thr7, Pro30, Pro43 and Pro56 are unique. Other
interface residues occur in very few non-FAS toxin
sequences (the number of sequences, out of 163, in
which these residues occur is shown in parentheses):
Thrl (4), Thr9 (4), Argll (4), Ala12 (4), Leul4 (1),
Asnl6 (5), Arg24 (5), Arg27 (1), His29 (1), Met33 (2),
Leu35 (5), Gly36 (2), Gly44 (2), Asp46 (1), Asn47 (4),
Leu48 (3) and Tyr61 (1). This includes six of the seven
residues in FAS-II that lose the most accessible surface
area upon complex formation and excludes Thr8, which
is found in 32 non-FAS toxin sequences. The seven
residues, in descending order of surface loss, are numbers
11, 9, 61, 8, 30, 33 and 27 (see Table 3). Pro56 is a
deletion in all other sequences; perhaps this residue is
required to orient the C terminus properly.
Role of basic residues
We have identified several critical basic residues within
the FAS molecule. Their key roles are in agreement with
earlier predictions made on the basis of the 3D structure
of FAS-I coupled with the effects of chemical modifica-
tions on the toxin's biological activity. Thus, both
acetylation of Lys32 and Lys51, and modification of
Argll and Arg27, greatly reduced the potency of FAS
[25,30]. Of these four basic residues, Argl 1 and Arg27
occur only rarely in other three-fingered toxins. As
detailed above (see Table 3), three of these residues make
important contacts in the AChE/FAS complex: Argl 1 in
FAS with Asn85 and Val71; Arg27 with Trp279; and
Lys32 with Tyr334. Arg27 also stabilizes the turn 29-31
in FAS. There is no structural evidence for involvement
of Lys51 of FAS in the interaction with AChE. It is
possible that its modification could perturb contacts
between loops III and II, and thus, indirectly, interaction
of loop II with AChE.
Role of electrostatic forces
It has been noted previously that AChE has a large dipole
moment (-1700 Debyes) aligned approximately along the
axis of the active-site gorge [20,22,36,42]. The field due
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to this dipole might actually draw the positively charged
substrate, ACh, towards and down the gorge to the active
site. Similarly, FAS-II has its charges separated (dipole
moment of -185 Debyes), with most basic residues
occurring in the first two fingers, and most acidic
residues in the third finger [24,33] (Fig. 8). As the first
two fingers make up most of the interface with AChE,
and the third finger lies away from AChE, visual inspec-
tion suggests that the dipole moments of both proteins
are roughly aligned in the complex. Indeed, electrostatic
calculations [43,44] show that the angle between the
dipole vectors of the two proteins is only -30 ° (see
Fig. 9) (C Felder, personal communication).
A priori, a reasonable mode of action of FAS, based on
the static crystal structure which we have described and
analyzed, would involve physical blocking of the mouth
of the active-site gorge, thereby preventing access of sub-
strate to the active site. Indeed, surface calculations, using
a 1.4 A probe radius, show that not even a water mol-
ecule would be able to penetrate the gorge in the crystal
structure of the complex. Kinetic data suggest, however,
that in solution, FAS does not completely seal off the
active site from the bulk solution. The stoichiometric
complex is still capable of reacting with organophosphate
inhibitors [27], and displays residual catalytic activity
[28,29]. In the Trp84--Ala mutant of mouse AChE,
binding of FAS actually enhances the rate of hydrolysis of
neutral esters [29]. The 3D model of the AChE/FAS
complex may provide a structural explanation for such an
allosteric effect, as the bound FAS-II molecule actually
spans the loop (residues 68-94). This loop is homolo-
gous to the 'lid' of the neutral lipases which, like AChE,
are members of the ot/ hydrolase fold family [45,46].
Thus, FAS makes contact not only with Tyr70 and
Trp279 in the peripheral site, but also stretches down the
outside of the thin aspect of the gorge to make contact,
via Argl 1, with Asn85, which lies adjacent to Trp84, the
key residue of the anionic subsite of the active site.
However, the crystal structure of the AChE/FAS com-
plex provides no clue as to the route by which substrates
and inhibitors, whether charged or neutral, penetrate to
the active site. This enigma is reminiscent of that encoun-
tered in the crystal structure of the native enzyme.
Although the entrance to the active-site gorge appeared
to be completely blocked by a symmetry-related subunit
in the crystal structure [36], no difficulty was experienced
in soaking several ligands into the native crystals [14,15].
Thus, the transition-state analog, m-(N,N,N-trimethyl-
ammonio)trifluoroacetophenone (TMTFA) [47], could
be soaked into crystals of native Torpedo AChE, and the
Fig. 8. Isopotential electrostatic surface
looking straight into the active-site
gorge of AChE, contoured at +1 kT e-1.
Negative surface potential is shown in
red and positive in blue. (a) AChE alone
showing the deep gorge, with red
surface over the gorge. (b) AChE/FAS-II
complex showing FAS-II covering the
gorge.
Fig. 9. Electrostatic potential with dipole
moments drawn showing the attraction
of FAS-II (top left) to AChE (bottom left)
and the complex of AChE/FAS-II (right).
The calculations were made assuming
a pH of 7.0 and physiological ionic
strength. The Ca trace of the structure of
AChE and FAS-II, drawn to the same
scale, is shown on the right.
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structure of the complex so obtained was solved [15].
However, in a preliminary experiment, a data set col-
lected on a crystal of the AChE/FAS complex which had
been exposed to 2 mM TMTFA for six days, revealed no
TMTFA within the active site (data not shown).
Grochulski and coworkers [48] have solved 3D structures
of neutral lipases in which the lid was either open or shut.
We must, therefore, face the possibility that the crystal
structures of both native AChE and the AChE/FAS com-
plex do not faithfully reflect the situation in solution.
'Batk doors' or 'side doors' may exist through which
traffic of substrate, products and water may occur [49],
either permanently or transiently.
Biological implications
Acetylcholinesterase (AChE), the enzyme which
hydrolyzes the neurotransmitter acetylcholine, is
inhibited selectively by some snake venom toxins.
Because of the relatively large size of these toxins
(60-70 residues), they are not expected to pene-
trate the deep and narrow gorge leading to the
active site of AChE but to inhibit it by binding at
its so-called 'peripheral' site.
We have determined the three-dimensional struc-
ture of a 1:1 complex between Torpedo californica
AChE and fasciculin-II (FAS-II), a three-fingered
toxin from the venom of the green mamba,
Dendroaspis angusticeps. In conjunction with muta-
genesis data, this has enabled us to propose a
model for the toxin's mode of action and the
inhibitory interactions at the peripheral site.
Indeed, the structure of the complex reveals physi-
cal blocking of the entrance to the AChE active-
site gorge by FAS-I. However, the static crystal
structure does not explain the fact that, in solu-
tion, the complex reacts with organophosphate
inhibitors and displays residual catalytic activity.
The high affinity of FAS for AChE can be attrib-
uted to a remarkable surface complementarity,
involving an unusually large contact area
(-2000 A2 ) and many residues either unique to
FAS or rare in other three-fingered toxins. Several
basic residues in FAS make important contacts
with AChE. Another striking feature is the lack of
intermolecular salt linkages at the AChE/FAS
interface. The two proteins also have large dipole
moments, that are roughly aligned in the com-
plex, suggesting that electrostatic forces may be
guiding the interaction.
Obviously, the generality of our findings with
respect to the mode of interaction of other three-
fingered toxins with their targets cannot be easily
assessed as long as the structure of the
AChE/FAS-II complex is the only one available.
Although the three-dimensional structures of
FAS-II and AChE separately and in their complex
are very similar, the flexibility of the structure of
the three-fingered toxins means that substantial
conformational change could occur upon com-
plexation of a given toxin with its target. Albrand
and coworkers [5] have analyzed the structural
differences between FAS-II and the Ca2+ channel
blocking FS2 toxin from black mamba venom. In
particular, these authors have suggested that
replacement of two aspartate residues in loop III
of FAS-II by hydrophobic residues in the FS2
toxin, deprives the latter of the dipole character of
FAS-II, and could help to explain why FS2 does
not display anticholinesterase activity. Overall, it is
likely that the flexibility of the three-fingered toxin
structure will result in a large area of surface com-
plementarity between toxin and target, leading to
high specificity and high affinity.
Materials and methods
Crystallization
Single crystals of AChE/FAS-II were grown by the vapor dif-
fusion method at 4C using 20-25% PEG 200, 0.1 M sodium
acetate buffer (pH 5.2), and 0.001 M zinc acetate in the reser-
voir. The 3 R.1 drops contained a 1:1 ratio of protein and
reservoir. The AChE/FAS-II solution contained a 1:1 stoichio-
metric mixture of Torpedo AChE (13 mg ml- ) and FAS-II
(2.3 mg ml-l). FAS-II was purified from Dendroaspis angusticeps
venom by Alomone Labs Jerusalem, Israel). Crystals belonging
to space group P2 1212 appeared overnight and grew, in a few
days, to a size of 0.3 mmxO.15 mmx0.15 mm.
Data collection
Data were collected at 90 K using the Brookhaven National
Laboratory NSLS beamline X12C, at 1.15 A, with a 30 cm
MAR image plate scanner. Two data sets were collected using
crystals with up to 7% differences in cell dimensions. Due to
these differences, the two data sets merged poorly (Rmerge
-29%) and were, therefore, kept separate for refinement and
map averaging. Data processing, scaling and merging was car-
ried out with DENZO and SCALEPACK [50].
Structure solution and refinement
The structure was solved by molecular replacement [51] using
the program AMORE [52], starting from the 2.3 A refined
structure of native AChE (MH, unpublished data). Both data
sets yielded a single clear solution; after rigid-body refinement,
the R-factors were 42% and 46%, and the correlation coeffi-
cients were 0.57 and 0.52 for data sets 1 and 2, respectively.
Refinement using X-PLOR [53], based on the AChE structure
alone, resulted in the R-factor initially dropping from 48.5% to
26.3% for F>lcr data. The Fo-F c map at 2.5a showed the possi-
ble location of FAS-II. The structure of FAS-I (PDB entry
IFAS) was fitted into this density. After rebuilding with O [54],
it was noted that loop I of FAS had undergone a major change,
with a maximum shift of 10.5 A for residue 9 at its tip.
Enhancement of the FAS portion of the map was achieved with
the program DMmulti (K Cowtan, unpublished program), in
the CCP4 program suite [55], which was used to average the
density of the maps of data set 1 and data set 2. The averaged
density confirmed that a major conformational change of loop I
had indeed occurred (Cot rmsd 2.6 A for all residues). At that
time, the structure of FAS-II became available (PDB entry
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1FSC) and was found to fit the rebuilt FAS-I molecule (Cat
rmsd 0.9 A). However, the free R-factor was high (39%) and
several areas in the FAS structure had poor electron density.
In view of the difficulties encountered in refinement, the cor-
rectness of the model of the complex was assessed using a six-
dimensional real-space rigid-body fitting procedure of a partial
FAS-II model in a map calculated with phase information from
the AChE alone (program ESSENS [GJK and TA Jones,
unpublished program]). This procedure yielded one outstand-
ing peak (15( above the average score; next best peak -9tr).
The crystal structure of FAS-II was then oriented and posi-
tioned according to the best solution and rebuilt in the map
calculated with AChE phases only. The 2.8 A structure of
AChE in complex with edrophonium (PDB entry lACK
[14]), together with the rebuilt FAS-II structure, were used as
the starting model for further refinement.
In view of the limited number of diffraction data [56], the
model of the AChE/FAS-II complex was refined conserva-
tively. Only one temperature factor per residue was refined,
and, during simulated-annealing refinement [57], harmonic
restraints were used to prevent artificial deviations from the
(higher resolution) starting models. The free R-factor [58] was
used throughout to monitor the progress of the refinement. In
between refinement cycles, the entire model was checked and
rebuilt carefully with O [54] and OOPS [59]. Besides conven-
tional 2Fo-F c and Fo-F c maps, systematic simulated-annealing
omit maps were used in one rebuilding cycle (omitting 10 pro-
tein residues at a time), and an averaged 2Fo-F c map (using
cross-crystal averaging [60] with the 3.2 A crystal form, data set
2) was used in the two final rebuilding cycles. Two zinc ions
and a conservative number of water molecules (36) were
included in the final model. In addition, one N-acetyl-
glucosamine moiety has been modeled (attached to Asn59 in
AChE). As in the native structure [12], residues 1-3, 536 and
537 in AChE were not observed in the density and are not
included in the model. However, residue 535 (not seen in the
native 2.8 A structure) is observed and there is weak density
for parts of the main chain for residues 486-491 (also not
observed in the native AChE structure). Residues 486-491
have, therefore, been modeled as alanine residues.
The final model has a crystallographic R-factor of 23.1% for all
data between 8.0 A and 3.0 A, the last-recorded value of the
free R-factor, prior to the final minimization, was 31.5%, cal-
culated using 975 reflections (7%) of the data not used in the
refinement. The stereochemistry was tightly restrained to ideal
values [61]. There are only two outlier residues in the
Ramachandran plot [62], both in AChE: Ser200 (the active-
site serine, an outlier in all ot/3 hydrolase structures [46]) and
Leu23. However, both residues have good density. Coordi-
nates of the final model and experimental structure-factor
amplitudes (for the 3.0 A data set) have been deposited with
the PDB [63] (ID codes FSS and FSS-SF, respectively).
Software
All map calculations were done with various programs in the
CCP4 package [55]. Maps were averaged with programs in the
RAVE package [60]. All refinement was carried out with
X-PLOR [53], using the Engh and Huber [61] force field. All
graphics operations, modeling and model building were done
with [54]. All models were subjected to critical quality
checks with 0, X-PLOR [53], PROCHECK [64] and
WHAT IF [65]. Surfaces were calculated with VOIDOO [66].
Figure la was prepared with MOLSCRIPT [67], Figures lb
and 2-5 with O [54] and Figures 8 and 9 with GRASP [43,44].
Note added in proof
In an independent study, the crystal structure of the complex
between mouse AChE and fasciculin-I has been determined
(Bourne, Y., Taylor, P. & Marchot, P. [1995] Cell 83,
503-512). A joint comparison of the coordinates of the two
complexes should yield important information concerning the
amino acid residues participating in the interaction between
the toxin and the enzyme in both complexes.
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